PROCEPT BioRobotics Corporation Fair Value Adjustment of Warrants
PROCEPT BioRobotics Corporation (PRCT) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2024-02-28
- PROCEPT BioRobotics Corporation fair value adjustment of warrants for the quarter ending 2022-03-31 was $0.00.
- PROCEPT BioRobotics Corporation fair value adjustment of warrants for the quarter ending 2021-12-31 was $14.00K, a 70.83% decline year-over-year.
- PROCEPT BioRobotics Corporation fair value adjustment of warrants for the quarter ending 2021-09-30 was -$16.00K.
- PROCEPT BioRobotics Corporation fair value adjustment of warrants for the quarter ending 2021-03-31 was -$24.00K.
- PROCEPT BioRobotics Corporation fair value adjustment of warrants for fiscal 2023 was $0.00.
- PROCEPT BioRobotics Corporation fair value adjustment of warrants for fiscal 2022 was $0.00.
- PROCEPT BioRobotics Corporation fair value adjustment of warrants for fiscal 2021 was -$64.00K.
- PROCEPT BioRobotics Corporation fair value adjustment of warrants for fiscal 2020 was -$185.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-06 | $14.00K derived: sum of 2 quarters · filed 2024-02-28 | -$2.00K derived: sum of 3 quarters · filed 2024-02-28 | |
| 2021-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$2.00K derived: sum of 2 quarters · filed 2024-02-28 | -$64.00K 10-K · filed 2024-02-28 | |
| 2021-09-30 | -$16.00K 10-Q · filed 2021-11-05 | -$78.00K 10-Q · filed 2021-11-05 | ||
| 2021-03-31 | -$24.00K 10-Q · filed 2022-05-06 | $24.00K derived: sum of 2 quarters · filed 2022-05-06 | -$118.00K derived: sum of 3 quarters · filed 2022-05-06 | |
| 2020-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$94.00K derived: sum of 2 quarters · filed 2022-03-22 | -$185.00K 10-K · filed 2022-03-22 | |
| 2020-09-30 | -$142.00K 10-Q · filed 2021-11-05 | -$233.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |